Evaluation of Hydroxychloroquine to Prevent CIPN
Conditions: Breast Cancer; Gynecologic Cancer; Early-stage Breast Cancer; Peripheral Neuropathy; Chemotherapy-induced Peripheral Neuropathy Intervention: Drug: Hydroxychloroquine Sponsor: University of Arizona Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Brain | Cancer | Cancer & Oncology | Chemotherapy | Hydroxychloroquine | Neurology | Research